Results 91 to 100 of about 2,988,667 (266)

Prodromal Lewy Body Symptoms and α‐Synuclein Seeding in Idiopathic Olfactory Dysfunction

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Early identification of pathological α‐synuclein deposition (αSynD) may improve understanding of Lewy body disorder (LBD) progression and enable timely disease‐modifying treatments. Objectives We investigated αSynD using a seed amplification assay and assessed prodromal LBD symptoms in individuals with idiopathic olfactory ...
Oskar Hoffmann McWilliam   +15 more
wiley   +1 more source

Olfactory neuroepithelium in the superior and middle turbinates: which is the optimal biopsy site?

open access: yesInternational Archives of Otorhinolaryngology, 2013
Summary Introduction: Olfactory neuroepithelium (ON) biopsy has several therapeutic applications for both disorders of olfaction and neurodegenerative diseases.
Fabio de Rezende Pinna   +4 more
doaj   +1 more source

Hyposmia in COVID-19: Temporal Recovery of Smell: A Preliminary Study

open access: yesMedicina, 2023
Background and Objectives: Hypo/anosmia is a characteristic symptom of COVID-19 infection. The aim of this study is to investigate the time of smell recovery and to identify a possible order of perception recovery of different odors in COVID-19 patients.
Barbara Verro   +2 more
doaj   +1 more source

LRRK2 as a Potential Disease‐Modifying Target in Sporadic Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract A growing understanding of the role that leucine‐rich repeat kinase 2 (LRRK2) plays in Parkinson's disease (PD) supports continued focus on this enzyme as a therapeutic target for PD. Accumulating evidence suggests that there are phenotypic, neuropathologic, and biological similarities between sporadic PD (sPD) and familial forms in which ...
Anthony E. Lang   +12 more
wiley   +1 more source

Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients

open access: yesViruses, 2023
This cross-sectional study aimed to investigate self-rated olfactory dysfunction in relation to measured olfactory function after partial or complete subjective recovery in individuals with a history of coronavirus disease 2019 (COVID-19) infection.
Emilia Cancellieri   +8 more
doaj   +1 more source

Discordance of Dopaminergic Dysfunction and Subcortical Atrophy by α‐Synuclein Status in Sporadic and Genetic Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Parkinson's disease (PD) is characterized by predominantly neuronal α‐synuclein pathology and dopaminergic dysfunction. Cerebrospinal fluid (CSF) seeding amplification assays (SAA) detect α‐synuclein aggregates in vivo, but not all patients with PD have a positive SAA.
Michael Tran Duong   +186 more
wiley   +1 more source

Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha‐Synuclein Seed Amplification Assay

open access: yesMovement Disorders, EarlyView.
Abstract Background The cerebrospinal fluid alpha‐synuclein seed amplification assay (CSFasynSAA) detects alpha‐synuclein aggregation in over 90% of individuals with sporadic PD (sPD). However, the clinical characteristics of sPD with negative CSFasynSAA remain undefined.
Sarah M. Brooker   +30 more
wiley   +1 more source

Odor Perception in Children with Autism Spectrum Disorder and its Relationship to Food Neophobia [PDF]

open access: yes, 2015
Atypical sensory functioning in Autism Spectrum Disorder (ASD) has been well documented in the last decade for the visual, tactile and auditory systems, but olfaction in ASD is still understudied.
Agnes Giboreau   +6 more
core   +3 more sources

Physiological barriers to oral intake in survivors of critical illness: A scoping review

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Oral nutrition is the predominant mode of nutrition delivery on the post–Intensive Care Unit (ICU) ward; yet, it is associated with lower intake than via enteral or parenteral nutrition. There are limited data on barriers that influence oral intake in ICU survivors.
Breanna J. Teleki   +4 more
wiley   +1 more source

Exploring New Chemical Paths in Quantum AI: Preliminary Accomplishments and Future Perspectives

open access: yesAdvanced Quantum Technologies, EarlyView.
Two new strategies derived from Chemical AI to promote the advancement of sustainable quantum technologies are presented and discussed. The first strategy relies on the chemical implementation of molecular fuzzy sets, which are quantum mixed states associated with chemical microheterogeneous systems. The second strategy relies on photochromic compounds
Pier Luigi Gentili
wiley   +1 more source

Home - About - Disclaimer - Privacy